Adam S. Mostafa, Chief Financial Officer at X4 Pharmaceuticals, Inc (XFOR), sold 461,290 shares at $0.73 ($337K) on 2023-11-01, disclosed to the SEC on 2023-11-03.
Scheduled sale ($337k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.73 | 230,645 | $168K | 50.0% |
| 2 | $0.73 | 230,645 | $168K | 50.0% |
| Total | $0.73 avg | 461,290 | $337K | 100% |
| Filing → |
| XFOR | SELL | 2024-03-11 | $46K | — | Filing → |
| XFOR | SELL | 2024-02-12 | $28K | — | Filing → |
| XFOR | SELL | 2023-07-05 | $5K | — | Filing → |